Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study

Shiwani Mahajan, Rajesh Srinivasan, Carrie A. Redlich, Sara K. Huston, Kelly Anastasio, Lisa Cashman, Daisy Massey, Andrew Dugan, Dan Witters, Jenny Marlar

Type: Article

Publication Date: 2020-10-29

Citations: 31

DOI: https://doi.org/10.1016/j.amjmed.2020.09.024

View Publication

Locations

The American Journal of Medicine - View
PubMed Central - View
The Journal of the American Medical Association (JAMA) Network (American Medical Association) - View - PDF
eScholarship@UMMS (University of Massachusetts Medical School) - View - PDF

Similar Works

Action	Title	Year	Authors
+ PDF Chat	SARS-CoV-2 Infection Hospitalization Rate and Infection Fatality Rate Among the Non-Congregate Population in Connecticut	2021	Shiwani Mahajan César Caraballo Shu-Xia Li Yike Dong Lian Chen Sara K. Huston Rajesh Srinivasan Carrie A. Redlich Albert I. Ko Jeremy Samuel Faust
+	SARS-CoV-2 Infection Hospitalization Rate and Infection Fatality Rate among the Non-Congregant Population in Connecticut	2020	Shiwani Mahajan César Caraballo Shu‐Xia Li Claire Dong Lian Chen Sara K. Huston Rajesh Srinivasan Carrie A. Redlich Albert I. Ko Jeremy Samuel Faust
+	Estimating the Cumulative Incidence of SARS-CoV-2 Infection and the Infection Fatality Ratio in Light of Waning Antibodies	2021	Kayoko Shioda Max S. Y. Lau Alicia N.M. Kraay Kristin N. Nelson Aaron J. Siegler Patrick S. Sullivan Matthew H. Collins Joshua S. Weitz Benjamin A. Lopman
+ PDF Chat	Estimating the cumulative incidence of SARS-CoV-2 infection and the infection fatality ratio in light of waning antibodies	2020	Kayoko Shioda Max S. Y. Lau Alicia N.M. Kraay Kristin N. Nelson Aaron J. Siegler Patrick S. Sullivan Matthew H. Collins Joshua S. Weitz Benjamin A. Lopman
+ PDF Chat	EpidemiologiCal POpulatioN STudy of SARS-CoV-2 in Lake CounTy, Illinois (CONTACT): Methodology and Baseline Characteristics of a Community-Based Surveillance Study	2022	Ryan D. Kilpatrick O. Sánchez-Soliño Negar N. Alami Christopher Johnson Yixin Fang Lani R. Wegrzyn Whitney S. Krueger Yizhou Ye Nancy A Dreyer Gregory C. Gray
+ PDF Chat	SARS-CoV-2 Viral Incidence, Antibody Point Prevalence, Associated Population Characteristics, and Vaccine Attitudes, South Carolina, February 2021	2022	Melissa S. Nolan Virginie Daguisé Megan Davis Joan Duwve Windsor Westbrook Sherrill Moonseong Heo Alain H. Litwin Mufaro Kanyangarara Stella Self Rongjie Huang
+	Changes in Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Over Time in 10 Sites in the United States, March–August, 2020	2021	Travis Lim Mark J. Delorey Nicolette Bestul Michael A Johannson Carrie Reed Aron J. Hall Alicia M. Fry Chris Edens Vera Semenova Li Han
+ PDF Chat	Estimated Community Seroprevalence of SARS-CoV-2 Antibodies — Two Georgia Counties, April 28–May 3, 2020	2020	Holly M. Biggs Jennifer B. Harris Lucy Breakwell F. Scott Dahlgren Glen R. Abedi Christine M. Szablewski Jan Drobeniuc Nirma D. Bustamante Olivia Almendares Amy H. Schnall
+ PDF Chat	SARS-CoV-2 IgG antibody seroprevalence in the general population of Indore City: A population-based cross-sectional study	2021	Ranjana Hawaldar Sadhna Sodani Varsha Sodani Ravitanaya Sodani
+ PDF Chat	Estimated seroprevalence of SARS-CoV-2 antibodies among adults in Orange County, California	2021	Tim A. Bruckner Daniel M. Parker Scott M. Bartell Verónica M. Vieira Saahir Khan Andrew Noymer Emily Drum Bruce Albala Matthew Zahn Bernadette Boden‐Albala
+ PDF Chat	Using publicly available data to identify priority communities for a SARS-CoV-2 testing intervention in a southern U.S. state	2023	Lynn T. Matthews Dustin Long Madeline C. Pratt Ya Yuan Sonya L. Heath Emily B. Levitan Sydney Grooms Thomas Creger Aadia Rana Michael J. Mugavero
+ PDF Chat	COVID-19 Testing Practices, Preventive Behaviors, and Factors Associated With Test Positivity: Population-Based Statewide Survey Study	2023	Mufaro Kanyangarara Virginie G. Daguisé Lídia Gual‐Gonzalez Alain H. Litwin Jeffrey E. Korte Connor Ross Melissa S. Nolan
+ PDF Chat	Mapping a Pandemic: SARS-CoV-2 Seropositivity in the United States	2021	Heather Kalish Carleen Klumpp‐Thomas Sally Hunsberger Holly Ann Baus Michael P. Fay Nalyn Siripong Jing Wang Jennifer Hicks Jennifer Mehalko Jameson Travers
+	SARS-CoV-2 Cumulative Incidence and Period Seroprevalence: Results From a Statewide Population-Based Serosurvey in California	2021	Katherine Lamba Heather Bradley Kayoko Shioda Patrick S. Sullivan Nicole Luisi Eric W. Hall Megha Mehrotra Esther Lim Seema Jain Amanda Kamali
+ PDF Chat	Estimating the period prevalence of SARS-CoV-2 infection during the Omicron (BA.1) surge in New York City (NYC), January 1-March 16, 2022	2022	Saba A Qasmieh McKaylee Robertson Chloe A. Teasdale Sarah Kulkarni Denis Nash
+ PDF Chat	Population Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random Sample — Indiana, April 25–29, 2020	2020	Nir Menachemi Constantin T. Yiannoutsos Brian E. Dixon Thomas J. Duszynski William F. Fadel Kara Wools‐Kaloustian Nadia Unruh Needleman Kristina Box Virginia Caine Connor W. Norwood
+	Assessing SARS-CoV-2 Testing Adherence in a University Town: Recurrent Event Modeling Analysis	2024	Yury E. García Alec J. Schmidt Leslie Solis Maria L. Daza–Torres J. Cricelio Montesinos-López Brad H. Pollock Miriam Nuño
+	Point prevalence of SARS-CoV-2 and infection fatality rate in Orleans and Jefferson Parish, Louisiana, May 9-15, 2020	2020	Amy K. Feehan Daniel Fort Julia Garcia‐Diaz Eboni G. Price‐Haywood Cruz Velasco‐Gonzalez Eric Sapp Dawn Pevey Leonardo Seoane
+	SARS-CoV-2 incidence and risk factors in a national, community-based prospective cohort of U.S. adults	2021	Denis Nash Madhura S. Rane Mindy Chang Sarah Kulkarni Rebecca Zimba William You Amanda Berry Chloe Mirzayi Shivani Kochhar Andrew Maroko
+	Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study	2020	Aude Richard Ania Wisniak Javier Perez‐Saez Henri M. Garrison‐Desany Dušan Petrović Giovanni Piumatti Hélène Baysson A. Picazio Francesco Pennacchio David De Ridder

Works That Cite This (25)

Action	Title	Year	Authors
+	Estimating seroprevalence of SARS-CoV-2 in Ohio: A Bayesian multilevel poststratification approach with multiple diagnostic tests	2021	David Kline Zehang Li Yue Chu Jonathan Wakefield William C. Miller Abigail Norris Turner Samuel J. Clark
+	Exploring Risks of Human Challenge Trials for COVID-19	2020	David Manheim Witold Więcek Virginia Schmit Josh Morrison
+	Seroprevalence of SARS-CoV-2-specific IgG antibodies in Kashmir, India, 7 months after the first reported local COVID-19 case: results of a population-based seroprevalence survey from October to November 2020	2021	Muhammad Salim Khan Mariya Amin Qurieshi Inaamul Haq Sabhiya Majid Javid Ahmad Taha Ayub Ashfaq Ahmad Bhat Anjum Fazili A.M. Ganai Yasmeen Jan
+ PDF Chat	SARS-CoV-2 Infection Hospitalization Rate and Infection Fatality Rate Among the Non-Congregate Population in Connecticut	2021	Shiwani Mahajan César Caraballo Shu-Xia Li Yike Dong Lian Chen Sara K. Huston Rajesh Srinivasan Carrie A. Redlich Albert I. Ko Jeremy Samuel Faust
+ PDF Chat	One year of modeling and forecasting COVID-19 transmission to support policymakers in Connecticut	2021	Olga Morozova Zehang Li Forrest W. Crawford
+ PDF Chat	SARS-CoV-2 seroprevalence around the world: an updated systematic review and meta-analysis	2022	Mobin Azami Yousef Moradi Asra Moradkhani Abbas Aghaei
+	Associations of SARS-CoV-2 serum IgG with occupation and demographics of military personnel	2021	Joseph Zell Jon Klein Carolina Lucas Martin Slade Jian Liu Akiko Iwasaki Adam V. Wisnewski Carrie A. Redlich
+	Associations of SARS-CoV-2 serum IgG with occupation and demographics of military personnel	2021	Joseph Zell Adam V. Wisnewski Jian Liu Jon Klein Carolina Lucas Martin D. Slade Akiko Iwasaki Carrie A. Redlich
+ PDF Chat	Dynamics of SARS-CoV-2 seroassay sensitivity: a systematic review and modelling study	2023	Nana Owusu‐Boaitey Timothy Russell Gideon Meyerowitz‐Katz Andrew Levin Daniel Herrera
+	Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis	2021	Xinhua Chen Zhiyuan Chen Andrew S. Azman Xiaowei Deng Ruijia Sun Zeyao Zhao Nan Zheng Xinghui Chen Wanying Lu Tingyu Zhuang

Works Cited by This (5)

Action	Title	Year	Authors
+ PDF Chat	Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study	2020	Silvia Stringhini Ania Wisniak Giovanni Piumatti Andrew S. Azman Stephen A. Lauer Hélène Baysson David De Ridder Dušan Petrović Stephanie Schrempft Kailing Marcus
+	Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York	2020	Eli S. Rosenberg James M. Tesoriero Elizabeth M. Rosenthal Rakkoo Chung Meredith A. Barranco Linda M. Styer Monica M. Parker Shu-Yin John Leung Johanne E. Morne Danielle Greene
+ PDF Chat	Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections	2020	Quanxin Long Xiao-Jun Tang Q L Shi Qin Li Haijun Deng Jun Yuan Jieli Hu Wei Xü Yong Zhang Fa-Jin Lv
+ PDF Chat	Estimated Community Seroprevalence of SARS-CoV-2 Antibodies — Two Georgia Counties, April 28–May 3, 2020	2020	Holly M. Biggs Jennifer B. Harris Lucy Breakwell F. Scott Dahlgren Glen R. Abedi Christine M. Szablewski Jan Drobeniuc Nirma D. Bustamante Olivia Almendares Amy H. Schnall
+ PDF Chat	Population Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random Sample — Indiana, April 25–29, 2020	2020	Nir Menachemi Constantin T. Yiannoutsos Brian E. Dixon Thomas J. Duszynski William F. Fadel Kara Wools‐Kaloustian Nadia Unruh Needleman Kristina Box Virginia Caine Connor W. Norwood